Back to Search
Start Over
Impact factors of benefiting from initial 131I ablation in patients with intermediate-risk differentiated thyroid carcinoma: a study based on a re-evaluation of therapeutic response.
- Source :
- Nuclear Medicine Communications; Mar2024, Vol. 45 Issue 3, p188-195, 8p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 01433636
- Volume :
- 45
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Nuclear Medicine Communications
- Publication Type :
- Academic Journal
- Accession number :
- 176023499
- Full Text :
- https://doi.org/10.1097/MNM.0000000000001807